Education
About Us
Working with TipRanks
Follow Us
Moonlake Immunotherapeutics (MLTX)
:MLTX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -1.38M | $ -13.16K | $ -12.36K | $ -4.97K | $ 0.00 |
| Operating Income | $ -143.09M | $ -54.12M | $ -65.06M | $ -53.58M | $ -105.76K |
| EBITDA | $ -119.58M | $ -54.11M | $ -65.05M | $ -53.63M | $ -90.84K |
| Net Income | $ -118.94M | $ -36.01M | $ -64.51M | $ -53.64M | $ -90.84K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 448.03M | $ 511.01M | $ 72.11M | $ 8.04M | $ 1.34M |
| Total Assets | $ 477.93M | $ 526.54M | $ 76.84M | $ 9.68M | $ 116.63M |
| Total Debt | $ 2.83M | $ 3.81M | $ 282.58K | $ 15.00M | $ 58.06K |
| Net Debt | $ -177.60M | $ -447.36M | $ -39.22M | $ 6.96M | $ -1.28M |
| Total Liabilities | $ 24.54M | $ 13.05M | $ 8.08M | $ 21.33M | $ 4.15M |
| Stockholders' Equity | $ 446.82M | $ 495.68M | $ 48.90M | $ -11.65M | $ 112.48M |
| Cash Flow | |||||
| Free Cash Flow | $ -117.11M | $ -43.06M | $ -55.91M | $ -35.23M | $ -316.69K |
| Operating Cash Flow | $ -116.59M | $ -42.78M | $ -55.89M | $ -35.18M | $ -316.69K |
| Investing Cash Flow | $ -205.60M | $ -25.18M | $ -32.34M | $ -50.71K | $ -115.00M |
| Financing Cash Flow | $ 51.31M | $ 479.70M | $ 119.69M | $ 43.26M | $ 116.65M |